The effect of the RELM extract on ascites tumor development is shown in Table 5. All the control animals died of EAC tumor by 19.16 days. All the treated groups showed an increase in life span of animals bearing EAC tumors. The administration of RELM significantly (p < 0.001, p < 0.01 reduced ascites tumor development by EAC cells when injected intraperitoneally. However, cyclophosphamide (10 mg/kg) was found to be more effective and increased the life span of animals by 83.56% (p < 0.001) whereas RELM 250 mg/kg, 100 mg/kg, and 50 mg/kg showed 45.76%, 39.93%, and 22.76% increase in life span, respectively.